To analyze the polymorphism of TAP gene and the shared rates of alleles between mothers and their infants in Chinese patients with pre-eclampsia, TAP1 and TAP2 genotyping was performed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) in 42 patients, 106 normal pregnant women, and their neonates. The allelic frequency of TAP and the alleles shared in maternal-fetus were compared and analyzed in the two groups. Our results showed that, with totally eight alleles of TAP1 and TAP2 examined in the samples, no significant difference was found in allelic frequencies between pre-eclampsia group and control group, as well as between mothers and their neonates. Similar finding was obtained in the comparison with shared alleles. In conclusion, our results do not support a role for the polymorphisms of TAP in the etiology of pre-eclampsia.

Download full-text PDF

Source

Publication Analysis

Top Keywords

tap1 tap2
12
chinese patients
8
patients pre-eclampsia
8
analysis tap1
4
tap2 polymorphism
4
polymorphism mother-infant
4
mother-infant chinese
4
pre-eclampsia
4
pre-eclampsia analyze
4
analyze polymorphism
4

Similar Publications

Major histocompatibility complex class I deficiency results from deleterious biallelic variants in TAP1, TAP2, TAPBP, and B2M genes. Only a few patients with variant-curated TAP1 deficiency (TAP1D) have been reported in the literature and the clinical phenotype has been variable with an emphasis on autoimmune and inflammatory complications. We report TAP1D in a Nepalese girl with a severe clinical phenotype with serious viral infections at a very young age.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudorabies virus (PRV) can create lifelong infections in nerve cells and blood lymphocytes, avoiding the immune system and potentially causing fetal death.
  • The virus evades immune responses by downregulating swine leukocyte antigen class I (SLA I) molecules, but the specific mechanisms behind this suppression are poorly understood.
  • Research shows that PRV proteins pUL44 and pUS6 significantly decrease SLA I expression, with pUS6 also affecting transport proteins that help present antigens, highlighting how PRV can hinder immune detection.
View Article and Find Full Text PDF

Type I bare lymphocyte syndrome with novel TAP1 and TAP2 pathogenic variants.

JAAD Case Rep

September 2024

Division of Dermatology, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

View Article and Find Full Text PDF

Determination of the Immunomodulatory Role of OTOP2 in Colon Adenocarcinoma.

J Cancer

July 2024

Department of Pathology, National Clinical Research Centre for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Centre for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu West Road, Hexi District, Tianjin 300060, China.

Article Synopsis
  • Otopetrin 2 (OTOP2) is a crucial ion channel protein involved in cell signaling and development, with its tumor-suppressing role highlighted in colon adenocarcinoma (COAD) studies.
  • * OTOP2 expression was found to be significantly decreased in COAD patients, and higher levels of OTOP2 were linked to better survival outcomes and immune responses.
  • * The research suggests that OTOP2 may serve as a valuable prognostic marker and predictor of immunotherapy effectiveness for patients with COAD.
View Article and Find Full Text PDF

Phenotypic and pathomechanistic overlap between tapasin and TAP deficiencies.

J Allergy Clin Immunol

October 2024

Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany. Electronic address:

Article Synopsis
  • Human tapasin deficiency leads to a significant reduction in MHC-I expression on the cell surface, which is linked to immune system issues and increased susceptibility to infections like herpes zoster.
  • A novel genetic variant in the TAPBP gene was found in a patient, resulting in this deficiency, and laboratory tests showed the deficiency affects both the transport proteins (TAP1 and TAP2) and MHC-I trafficking to the membrane.
  • Treatment with IFN-α was shown to enhance MHC-I expression on the surface of affected cells, providing a possible therapeutic direction for those with tapasin deficiency.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!